Blastocystosis in patients with gastrointestinal symptoms: a case–control study

BMC Gastroenterology

Basak Oguz Yolcular¹  Fatma Gulsun Koclar²  Ezel Tasdemir⁵  Yesim Adakan⁵  Yesim Cekin³  Ayhan Hilmi Cekin⁴ 

[1] Department of Biostatistics and Medical Informatics, Akdeniz University Faculty of Medicine, Antalya, Turkey;Department of Parositology, Antalya Training and Research Hospital, Antalya, Turkey;Department of Microbiology, Antalya Training and Research Hospital, Antalya, Turkey;Deparment of Gastroenterology, Antalya Training and Research Hospital, Antalya, Turkey;Department of Internal Medicine, Antalya Training and Research Hospital, Antalya, Turkey

关键词: Blastocystis spp;    Irritable bowel syndrome;    Crohn’s disease;    Ulcerative colitis;   

Others  :  1088670
DOI  :  10.1186/1471-230X-12-122

 received in 2011-12-17, accepted in 2012-08-31,  发布年份 2012

【 摘 要 】

Background

Blastocystosis is a frequent bowel disease. We planned to to evaluate the prevalence of Blastocystis spp. in patients who applied to the same internal medicine-gastroenterology clinic with or without gastrointestinal complaints to reveal the association of this parasite with diagnosed IBS and IBD.

Methods

A total of 2334 patients with gastrointestinal symptoms composed the study group, which included 335 patients with diagnosed inflammatory bowel disease and 877 with irritable bowel syndrome. Patients without any gastrointestinal symptoms or disease (n = 192) composed the control group. Parasite presence was investigated by applying native-Lugol and formol ethyl acetate concentration to stool specimens, and trichrome staining method in suspicious cases.

Results

Blastocystis spp. was detected in 134 patients (5.74%) in the study group and 6 (3.12%) in the control group (p = 0.128). In the study group, Blastocystis spp. was detected at frequencies of 8.7% in ulcerative colitis (24/276), 6.78% in Crohn’s disease (4/59), 5.82% in irritable bowel syndrome (51/877), and 4.9% in the remaining patients with gastrointestinal symptoms (55/1122). Blastocystis spp. was detected at a statistically significant ratio in the inflammatory bowel disease (odds ratio [OR] = 2.824; 95% confidence interval [CI]: 1.149-6.944; p = 0.019) and ulcerative colitis (OR = 2.952; 95% CI: 1.183-7.367; p = 0.016) patients within this group compared to controls. There were no statistically significant differences between the control group and Crohn’s disease or irritable bowel syndrome patients in terms Blastocystis spp. frequency (p = 0.251, p = 0.133).

Conclusions

Blastocystosis was more frequent in patients with inflammatory bowel disease, especially those with ulcerative colitis. Although symptomatic irritable bowel syndrome and Crohn’s disease patients had higher rates of Blastocystis spp. infection, the differences were not significant when compared to controls.

【 授权许可】

   
2012 Cekin et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Al FD, Hökelek M: Is Blastocystis hominis an opportunist agent? Turkiye Parazitol Derg 2007, 31:28-36.
• [2]Ustün S, Turgay N: Blastocystis hominis and bowel diseases. Turkiye Parazitol Derg 2006, 30:72-76.
• [3]Kuo HY, Chiang DH, Wang CC, Chen TL, Fung CP, Lin CP, Cho WL, Liu CY: Clinical significance of Blastocystis hominis: experience from a medical center in northern Taiwan. J Microbiol Immunol Infec 2008, 41:222-226.
• [4]Rhongbutsri P: Seasonal prevalence of Blastocystis hominis among patients attending Thammasat Chalermprakiat Hospital, Pathum Thani Province, Thailand. J Trop Med Parasitol 2005, 28:39-42.
• [5]Garcia LS: Diagnostic Medical Parasitology. 4th edition. American Society for Microbiology, Washington DC; 2001:28-35.
• [6]Noel C, Dufernez F, Gerbod D, Edgcomb VP, Delgado-Viscogliosi P, Ho LC, Singh M, Wintjens R, Sogin ML, Capron M, Pierce R, Zenner L, Viscogliosi E: Molecular phylogenies of Blastocystis isolates from different hosts: implications for genetic diversity, identification of species, and zoonosis. J Clin Microbiol 2005, 43:348-355.
• [7]Tan KS: New insights on classification, identification, and clinical relevance of Blastocystis spp. Clin Microbiol Rev 2008, 21:639-665.
• [8]Carrascosa M, Martinez J, Perez-Castrillon JL: Hemorrhagic proctosigmoiditis and Blastocystis hominis infection. Ann Intern Med 1996, 124:278-279.
• [9]Hussain R, Jafri W, Zuberi S, Baqai R, Abrar N, Ahmed A, Zaman V: Significantly increased IgG2 subclass antibody levels to Blastocystis hominis in patients with irritable bowel syndrome. AmJTrop Med Hyg 1997, 56:301-306.
• [10]Yakoob J, Jafri W, Beg MA, Abbas Z, Naz S, Islam M, Khan R: Blastocystis hominis and Dientamoeba fragilis in patients fulfilling irritable bowel syndrome criteria. Parasitol Res 2010, 107:679-684.
• [11]Yakoob J, Jafri W, Jafri N, Khan R, Islam M, Beg MA, Zaman V: Irritable bowel syndrome: in search of an etiology: role of Blastocystis hominis. AmJTrop Med Hyg 2004, 70:383-385.
• [12]Leber AL, Novak SM: Intestinal and urogenital Amebae, Flagellates, and Ciliates. In Manuel of Clinical Microbiology. Volume 2. 8th edition. Edited by Murray PR. Churchill Livingstone, Philadelphia; 2003:1990-2007.
• [13]Kuo HY, Chiang DH, Wang CC, Chen TL, Fung CP, Lin CP, Cho WV, Liu CY: Clinical significance of Blastocystis hominis: experience from a medical center in northern Taiwan. J Microbiol Immunol Infect 2008, 41:222-226.
• [14]Amin OM: Seasonal prevalence of intestinal parasites in the United States during 2000. AmJTrop Med Hyg 2002, 66:799-803.
• [15]Amin OM: The epidemiology of Blastocystis hominis in the United States. Res J Parasitol 2006, 1:1-10.
• [16]Elwakil HS, Hewedi IH: Pathogenic potential of Blastocystis hominis in laboratory mice. Parasitol Res 2010, 107:685-689.
• [17]Janarthanan S, Khoury N, Antaki F: An unusual case of invasive Blastocystis hominis infection. Endoscopy 2011, 43(Suppl 2):185-186.
• [18]Patino WD, Cavuoti D, Banerjee SK, Swartz K, Ashfaq R, Gokaslan T: Cytologic diagnosis of Blastocystis hominis in peritoneal fluid: a case report. Acta Cytol 2008, 52:718-720.
• [19]Abdel-Hameed DM, Hassain DM: Proteaese activity of Blastocystis hominis subtype 3 in symptomatic and asymptomatic patients. Parasitol Res 2011, 109:321-327.
• [20]Rostami Nejad M, Nazemalhosseini Mojarad E, Dabiri H, Nochi Z, Pourhoseingholi MA, Sahebekhtiari N, Habibi M, Zali MR: A case–control study of Blastocystis hominis among Iranian population. East Afr J Public Health 2010, 7:101-104.
• [21]Ramirez-Miranda ME, Hernandez-Castellanos R, Lopez-Escamilla E, Moncada D, Rodriguez-Magallan A, Pagaza-Melero C, Gonzalez-Angulo A, Flisser A, Kawa-Karasik S, Maravilla P: Parasites in Mexican patients with irritable bowel syndrome: a case–control study. Parasit Vectors 2010, 13:93-96.
• [22]Levy RL, Whitehead WE, Von Korff MR, Feld AD: Intergenerational transmission of gastrointestinal illness behavior. Am J Gastroenterol 2000, 95:451-456.
• [23]Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC: Functional bowel disorders. Gastroenterology 2006, 130:1480-1491.
• [24]Boorom KF, Smith H, Nimri L, Viscogliosi E, Spanakos G, Parkar U, Li LH, Zhou XN, Ok UZ, Leelayoova S, Jones MS: Oh my aching gut: irritable bowel syndrome, Blastocystis, and asymptomatic infection. Parasit Vectors 2008, 21:1-40.
• [25]Yakoop J, Jafri W, Beg MA, Abbas Z, Naz S, Islam M, Khan R: Irritable bowel syndrome; is it associated with genotypes of Blastocystis hominis. Parasitol Res 2010, 106:1033-1038.
• [26]Giacometti A, Cirioni O, Fiorentini A, Fortuna M, Scalise G: Irritable bowel syndrome in patients with Blastocystis hominis infection. Eur J Clin Microbiol Infect Dis 1999, 18:436-439.
• [27]Yamamoto-Furusho JK, Torijano-Carrera E: Intestinal protozoa infections among patients with ulcerative colitis: prevalence and impact on clinical disease course. Digestion 2010, 82:18-23.
• [28]Tai WP, Hu PJ, Wu J, Lin XC: Six ulcerative colitis patients with refractory symptoms co-infective with Blastocystis hominis in China. Parasitol Res 2011, 108:1207-1210.
• [29]Mylonaki M, Langmead L, Pantes A, Johnson F, Rampton DS: Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool. Eur J Gastroenterol Hepatol 2004, 16:775-778.
• [30]Nagler J, Brown M, Soave R: Blastocystis hominis in inflammatory bowel disease. J Clin Gastroenterol 1993, 16:109-112.
• [31]Dogruman-Al F, Simsek Z, Boorom K, Ekici E, Sahin M, Tuncer C, Kustimur S, Altınbas A: Comparison of methods for detection of Blastocystis infection in routinely submitted stool samples, and also in IBS/IBD patients in Ankara,Turkey. PLoS One 2010, 5(11):e15484.
• [32]Fouad SA, Basyoni MM, Fahmy RA, Kobaisi MH: The pathogenic role of different Blastocystis hominis genotypes isolated from patients with irritable bowel syndrome. Arab J Gastroenterol 2011, 12:194-200.
• [33]Boorom KF: Is this recently characterized gastrointestinal pathogen responsible for rising rates of inflammatory bowel disease (IBD) and IBD associated autism in Europe and the United States in the 1990s? Med Hypotheses 2007, 69:652-659.